ageas SA/NV (AGESY) Income Statement Analysis

See more : MediPress Health-Limited Partnership (MPRS.TA) Income Statement Analysis – Financial Results

Complete financial analysis of ageas SA/NV (AGESY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ageas SA/NV, a leading company in the Insurance – Diversified industry within the Financial Services sector.

You may be interested

ageas SA/NV (AGESY)

Industry: Insurance - Diversified

Sector: Financial Services

Website: https://www.ageas.com

About ageas SA/NV

ageas SA/NV, together with its subsidiaries, engages in insurance business in Europe and Asia. The company primarily offers property, casualty, and life insurance products, as well as pension products; and reinsurance products. Its life insurance products include risks related to the life and death of individuals; and non-life insurance products comprise accident and health, motor, fire, and other insurance products, as well as other damages to property covering the risk of property losses or claims liabilities. The company serves private individuals, as well as small, medium-sized, and large companies through independent brokers and the bank channels. ageas SA/NV was founded in 1824 and is headquartered in Brussels, Belgium.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Revenue	7.53B	9.58B	13.04B	11.63B	14.19B	11.03B	11.85B	13.45B	13.17B	13.43B	13.11B	14.56B	12.22B	13.63B	15.78B	9.57B	118.92B	94.36B	90.42B	54.59B	50.10B
Cost of Revenue	-3.72B	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gross Profit	11.25B	9.58B	13.04B	11.63B	14.19B	11.03B	11.85B	13.45B	13.17B	13.43B	13.11B	14.56B	12.22B	13.63B	15.78B	9.57B	118.92B	94.36B	90.42B	54.59B	50.10B
Gross Profit Ratio	149.36%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	24.00M	144.00M	121.00M	126.00M	165.40M	139.80M	137.70M	146.10M	131.20M	108.10M	104.70M	111.90M	103.20M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	65.00M	62.00M	62.00M	60.00M	67.50M	55.60M	58.00M	69.30M	78.10M	73.50M	74.40M	83.40M	79.10M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	89.00M	206.00M	183.00M	186.00M	232.90M	195.40M	195.70M	215.40M	209.30M	181.60M	179.10M	195.30M	182.30M	0.00	0.00	644.00M	4.98B	0.00	0.00	0.00	0.00
Other Expenses	9.76B	-8.38B	-12.72B	-10.95B	-13.85B	-10.07B	-11.07B	-1.40B	-721.70M	-1.18B	-683.50M	-1.95B	-12.67B	-540.00M	-1.99B	2.65B	-1.73B	-2.25B	-1.08B	6.13B	-47.84B
Operating Expenses	9.85B	-8.18B	-12.53B	-10.76B	-13.62B	-9.87B	-10.87B	-1.19B	-512.40M	-994.20M	-504.40M	-1.76B	-12.67B	-540.00M	-1.99B	3.29B	3.25B	-2.25B	-1.08B	6.13B	-47.84B
Cost & Expenses	9.85B	8.13B	11.80B	10.10B	12.76B	9.78B	10.74B	13.01B	12.00B	12.63B	12.12B	13.30B	12.98B	13.49B	14.15B	10.05B	116.10B	88.92B	85.27B	50.70B	47.84B
Interest Income	0.00	1.89B	1.84B	1.86B	1.93B	1.99B	2.10B	2.30B	2.39B	2.40B	2.44B	2.50B	3.09B	3.01B	3.12B	3.09B	94.87B	72.58B	66.84B	41.19B	26.69B
Interest Expense	275.00M	167.00M	126.00M	118.00M	108.50M	93.40M	98.00M	119.40M	123.60M	125.90M	168.30M	218.30M	310.00M	298.40M	498.00M	1.34B	87.35B	65.12B	60.23B	34.35B	19.73B
Depreciation & Amortization	299.00M	284.00M	181.00M	180.00M	175.50M	110.40M	110.50M	209.40M	749.40M	951.40M	793.70M	798.70M	686.90M	606.90M	575.00M	375.00M	805.00M	832.00M	967.40M	791.80M	19.73B
EBITDA	557.00M	2.28B	1.34B	1.72B	1.23B	1.83B	1.72B	1.11B	1.87B	1.69B	1.78B	2.10B	199.10M	1.05B	2.72B	1.24B	2.21B	71.33B	66.34B	39.37B	21.99B
EBITDA Ratio	7.40%	23.82%	10.25%	14.79%	8.69%	16.60%	14.53%	8.23%	14.19%	12.59%	13.56%	14.41%	1.97%	7.68%	17.13%	-273.64%	77.29%	75.60%	6.71%	72.12%	43.89%
Operating Income	1.40B	1.41B	503.00M	866.00M	579.30M	1.16B	979.40M	434.70M	1.17B	793.00M	993.00M	1.52B	-446.80M	425.30M	1.18B	-504.00M	2.83B	68.33B	5.15B	32.11B	2.25B
Operating Income Ratio	18.54%	14.68%	3.86%	7.45%	4.08%	10.47%	8.26%	3.23%	8.85%	5.91%	7.57%	10.46%	-3.66%	3.12%	7.47%	-5.26%	2.38%	72.41%	5.70%	58.82%	4.50%
Total Other Income/Expenses	32.00M	-5.44B	-11.24B	-9.44B	-12.33B	-9.43B	-10.51B	-11.92B	-11.40B	-12.37B	-11.35B	416.80M	-756.80M	-284.10M	451.00M	27.00M	-2.71B	-62.94B	0.00	-29.22B	0.00
Income Before Tax	1.43B	1.45B	1.23B	1.53B	1.43B	1.25B	1.11B	434.70M	1.17B	793.00M	993.00M	1.27B	-756.80M	141.20M	1.63B	-477.00M	2.83B	5.44B	5.15B	3.89B	2.25B
Income Before Tax Ratio	18.97%	15.15%	9.44%	13.18%	10.09%	11.33%	9.35%	3.23%	8.85%	5.91%	7.57%	8.70%	-6.19%	1.04%	10.33%	-4.98%	2.38%	5.77%	5.70%	7.13%	4.50%
Income Tax Expense	251.00M	229.00M	215.00M	233.00M	254.50M	252.80M	258.20M	211.90M	226.00M	137.20M	246.40M	338.90M	-83.30M	-222.60M	318.00M	108.00M	-235.00M	1.03B	1.16B	1.03B	499.00M
Net Income	953.00M	1.10B	845.00M	1.14B	979.00M	809.10M	623.20M	27.10M	770.20M	475.60M	569.50M	743.00M	-673.50M	363.80M	1.33B	-28.02B	3.99B	4.35B	3.94B	3.20B	1.76B
Net Income Ratio	12.66%	11.45%	6.48%	9.81%	6.90%	7.34%	5.26%	0.20%	5.85%	3.54%	4.34%	5.10%	-5.51%	2.67%	8.43%	-292.72%	3.36%	4.61%	4.36%	5.86%	3.50%
EPS	5.19	5.49	4.52	6.07	5.09	4.11	3.09	0.13	3.57	2.13	2.49	3.13	-2.65	0.90	4.90	-122.05	23.00	28.30	25.70	20.96	11.32
EPS Diluted	5.18	5.49	4.52	6.07	5.08	4.11	3.09	0.13	3.57	2.13	2.49	3.13	-2.64	0.90	4.90	-122.01	20.40	28.00	25.37	20.26	11.32
Weighted Avg Shares Out	183.67M	184.16M	186.77M	187.94M	192.53M	196.78M	201.77M	208.52M	215.54M	223.06M	228.74M	237.45M	254.61M	248.23M	247.50M	229.59M	173.60M	154.00M	153.25M	152.52M	155.07M
Weighted Avg Shares Out (Dil)	183.82M	184.32M	186.91M	188.10M	192.60M	196.93M	201.99M	208.93M	216.13M	223.63M	229.26M	237.67M	254.67M	248.24M	247.55M	229.66M	201.19M	158.53M	158.25M	157.78M	155.07M

Best Income Stocks to Buy for April 11th

April 11, 2023zacks.com

AGESY and GBX made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 11, 2023.

ageas: A 7.5% Yield Trading At Less Than 8 Times 2023 Earnings

April 5, 2023seekingalpha.com

ageas is a Belgian insurance company focusing on both life and non-life insurance contracts. The book value dropped due to the lower value of the investment portfolio due to the higher interest rates.

AGESY vs. ZURVY: Which Stock Is the Better Value Option?

March 29, 2023zacks.com

AGESY vs. ZURVY: Which Stock Is the Better Value Option?

Are Investors Undervaluing Ageas (AGESY) Right Now?

March 22, 2023zacks.com

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...

3 Highly Ranked Stocks with Dividend Yields Over 7%

March 16, 2023zacks.com

The rising earnings estimate revisions are a great sign that these companies are benefiting from a strong business environment which should lead to more upside in their stocks along with the passive income.

Here's Why Ageas SA (AGESY) Could be Great Choice for a Bottom Fisher

March 16, 2023zacks.com

After losing some value lately, a hammer chart pattern has been formed for Ageas SA (AGESY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for...

Should Value Investors Buy Ageas (AGESY) Stock?

March 6, 2023zacks.com

Best Income Stocks to Buy for February 27th

February 27, 2023zacks.com

IVR, ARI and AGESY made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 27, 2023.

ageas SA/NV (AGESF) Q4 2022 Earnings Call Transcript

February 22, 2023seekingalpha.com

ageas SA/NV (OTCPK:AGESF) Q4 2022 Results Conference Call February 22, 2023 3:00 AM ET Company Participants Hans De Cuyper - Chief Executive Officer Christophe Boizard - Chief Financial Officer Emmanuel Van Grimbergen - CRO Antonio Cano - Managing Director, Europe...